Lineage Cell Therapeutics (LCTX) Q4 2025 Earnings

Nov 6Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.13
-0.09
-0.06
-0.02

Details

Expected EPS
-0.025714
Actual EPS
-0.13
Surprise EPS
-0.1
Surprise Percent
-405.56%

Description

⁨Lineage Cell Therapeutics⁩ (⁦LCTX⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts